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T Cell-Independent Somatic Hypermutation
in Murine B Cells with an Immature Phenotype
We asked whether somatic hypermutation contrib-
utes to the diversity of the repertoire of murine immuno-
globulin genes and whether AID is expressed early dur-
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somatic variants will be expanded because of strongDepartment of Pediatrics
selective pressure. Indeed, receptor editing in the earlyHarvard Medical School
stages of B cell development, another mechanism ofBoston, Massachusetts 02115
diversification of the repertoire, was first discovered in
a similar experimental situation (Gay et al., 1993;
Kleinfield et al., 1986; Tiegs et al., 1993).Summary
Four models were chosen for analysis: / mice, QM
mice, QM C4/ mice, and QM C4/ CD3/ mice. /Somatic hypermutation contributes to the generation
mice have a -restricted repertoire (Chen et al., 1993;of antibody diversity and is strongly associated with
Zou et al., 1993). Since there are only three V germ linethe maturation of antigen-specific immune responses.
genes (V1, V2, and Vx) (Blomberg et al., 1981; DildropWe asked whether somatic hypermutation also plays
et al., 1987), there is only limited light chain diversity.a role in the generation of the murine immunoglobulin
We also used the quasi-monoclonal (QM) mouse thatrepertoire during B cell development. To facilitate
has an even more restricted Ig V gene repertoire (Cas-identification of somatic mutations, we examined
calho et al., 1996). QM mice are heterozygous at themouse systems in which only antibodies expressing
heavy chain locus: on one allele, the JH region is replaced1, 2, and x light chains can be generated. Somatic
by the rearranged VHDJH of an anti-NIP hybridomamutations were found in cells, which, by surface mark-
17.2.25 (Boersch-Supan et al., 1985); the other allele isers, RAG expression, and rapid turnover, had the phe-
nonfunctional because of a targeted deletion of all JHnotype of immature B cells. In addition, expression of
gene segments. Because QM mice are also homozy-AID was detected in these cells. The mutations were
gous for the J deletion, they produce only  light chains.limited to V regions and were localized in known hot-
Thus, in the QM mouse all newly derived B cells havespots. Mutation frequency was not diminished in the
the 17.2.25 VDJ heavy chain paired with a  chain en-absence of T cells. Our results support the idea that
coded by one of the three V genes.somatic hypermutation can occur in murine immature
The complement C4 component and complement re-B cells and may represent a mechanism for enlarging
ceptors CD21/CD35 contribute to negative selection ofthe V gene repertoire.
self-reactive B cells (Prodeus et al., 1998). Self-reactive
immature B cells generated by rearrangement areIntroduction
known to mature in C4-deficient mice. One expectation
is that in C4-deficient mice cells that are self-reactiveIn mice and humans the preimmune repertoire is
will accumulate mutations after self-antigen stimulation.
achieved primarily by gene rearrangement mechanisms.
Thus, in C4/ mice (Fischer et al., 1996) the frequency
Additional diversity in the repertoire can also be gener-
and range of mutations in B cells may be increased,
ated by other mechanisms, such as gene conversion, making their study less labor intensive. We therefore
as in birds (Reynaud et al., 1987), rabbits (Becker and studied QM mice that were bred to be C4 complement
Knight, 1990), cattle (Parng et al., 1996), and swine (But- factor deficient (C4/).
ler et al., 1996). In general, in humans and mice, somatic hypermuta-
Somatic hypermutation also serves to diversify B cell tion has been described as occurring in the context
receptors. The process of somatic hypermutation has of germinal centers after antigen stimulation and in a
been shown to require activation-induced cytidine de- manner that is dependent on T cell help (Kelsoe, 1995).
aminase (AID) expression (Muramatsu et al., 2000). Recent reports, however, suggest that somatic hyper-
There is evidence that AID directly modifies the DNA mutations can be T cell independent (Toellner et al.,
of its target genes (Petersen-Mahrt et al., 2002). When 2002; Monson, 2001; Weller et al., 2001). In addition,
expressed in fibroblast cells, AID can also mutate a in sheep, rabbits, and cattle, somatic hypermutation in
target gene, indicating that AID is the only lymphocyte- immature B cells appears to contribute to diversity of
specific component of the mutator complexes (Yoshi- the preimmune repertoire (Lucier et al., 1998; Reynaud
kawa et al., 2002). In mice AID is most abundant in et al., 1995; Weinstein et al., 1994). Therefore, we also
Peyer’s patch and lymph node cells, and much less in studied mice made T cell deficient by gene-targeted
spleen and bone marrow cells (Muramatsu et al., 1999). deletion of CD3 (DeJarnette et al., 1998).
Overall, we asked whether mice can generate somatic
mutations in bone marrow B cells with an immature*Correspondence: thereza.imanishi-kari@tufts.edu
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Figure 1. The 493IgM Bone Marrow B
Cells Have an Immature Surface Marker
Phenotype
(A) Surface marker expression in immature,
transitional, and mature B cells.
(B) An example of expression of 493 and IgM
on bone marrow cells. Gates used to identify
493IgM (immature and transitional) B cells
and 493IgM (mature) B cells are shown.
(C) Analysis of CD21 and IgD on gated 493
IgM cells (solid line) and on gated 493IgM
cells (dotted line). Representative data from
one of three mice of each genotype are
shown.
phenotype and whether such mutations are T depen- cated that only a small fraction was CD21low (17  6%),
or IgDlow (8  5%) (Figure 1C). We conclude that 80%dent. We found T-independent AID expression and so-
matic mutations in immature B cells in all of the four of the 493 bone marrow B cells from our mutant mice
have an immature surface phenotype and the remainingmodels examined.
20% have transitional B cell markers (for convenience,
we refer to them together as immature B cells in theResults
rest of the text), whereas 493 bone marrow B cells from
our mutant mice have mature B cell markers.Most 493 Bone Marrow B Cells from /,
It is generally agreed that in wild-type mice pro-, pre-,QM, and QM C4/ Mice Have
and immature B cells have a rapid turnover. This con-an Immature B Cell Phenotype
trasts with the longer half life of mature B cells and theBecause we wanted to look for somatic mutation in
observation that memory B cells are essentially restingdeveloping B cells, we needed a strategy to isolate
(Allman et al., 2001; Forster et al., 1989; Rolink et al.,pre-B, immature, and mature B cells from the bone mar-
1998). To determine whether the 493 bone marrow Brow. Newly emergent immature B cells are 493B220low
cell populations in our mutant mice are also rapidly turn-HSAhighIgMIgDCD21 (Hardy and Hayakawa, 2001;
ing over, we labeled bone marrow cells from /, QM,Loder et al., 1999). These immature B cells develop into
and QM C4/ in vivo with BrdU and followed BrdU493B220lowIgMIgDlowCD21int transitional B cells, which
labeling over time. We monitored the level of BrdU label-further develop into 493B220hiIgMIgDhiCD21 mature
ing in pre-, immature, and mature B cells by surfaceB cells (Figure 1A). We identified bone marrow 493 B
staining with 493 and anti-IgM (or anti-), and intracellu-cells in /, QM, and QM C4/ mice (Figure 1B), and
lar BrdU staining. Estimated initial rates of BrdU labelingcharacterized them further by staining for IgD, B220,
in QM C4/ mice were: 22% per hour for 493 largeHSA, and CD21. The 493 B cells from these mice were
pro-B, 2% per hour for 493 small pre-B, 1.7% per hourB220lowHSAhigh (data not shown; see Supplemental Fig-
for 493 immature B cells, and 0.7% per hour for 493ure S1 at http://www.immunity.com/cgi/content/full/20/
mature B cells (Figure 2A). These rates are in agreement2/133/DC1) as expected (Rolink et al., 1998). Most of
with the published data (Opstelten and Osmond, 1983).the 493 B cells were IgD, CD21. Analysis of bone
marrow cells from three individual mice per group indi- The large pro-B, small pre-B, and immature B cell popu-
Somatic Hypermutation in Immature B Cells
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Figure 2. In Mutant Mice Only Pre-B and Im-
mature B Cells Rapidly Incorporate BrdU
Ten-week-old QM C4/ mice were injected
with BrdU at 0 hr and then fed continuously
with drinking water containing BrdU. At the
indicated time points during BrdU feeding,
bone marrow cells were harvested for analy-
sis by FACS. The bone marrow cells were
stained with 493 and anti-IgM, permeabilized,
and stained with anti-BrdU antibodies. The
percent of BrdU cells in the indicated B lin-
eage populations at different time points is
shown. Results from identical time points
represent a single mouse. Similar results
were obtained with / and QM mice (data
not shown).
lations were 70% labeled before incorporation tapered not done) (Figure 3B). In the immature B cells, RAG1
expression can be seen in the 104 cell sample. RAG2off. All three populations eventually plateau at more than
90% labeled cells, which indicates that these cells are was not detected. Another source of mature B cells,
Peyer’s patch B cells, was also tested for RAG geneall rapidly turning over. In contrast, the maximum label-
ing of mature B cells was 40%, indicating a low turnover expression. No RAG was detected in samples of 5 
104 B220low and B220high cells from Peyer’s patchesrate. Similar results were obtained when anti-was used
instead of anti-IgM (data not shown). Thus, as in wild- of C57BL/6 mice (Figure 3C). In conclusion, the data
show that RAG1/2 are expressed at high levels in pro-/type mice, bone marrow 493 B cells in QM C4/ mice
have a rapid turnover rate. Moreover, the similarity of pre-B cells, less in immature B cells, and are not de-
tected in mature B cells. These data indicated thatBrdU labeling kinetics of the 493 small pre-B cells and
the 493 B cells suggests that the latter were the direct sorted 493B220 B cells from QM, QM C4/, and
QM C4/ CD3/ mice are indeed immature B cellsdescendants of the 493 small pre-B cells (Figure 2A).
This is consistent with the notion that the 493 B cells and are similar to those found in normal, wild-type mice.
from mutant mice are newly derived immature B cells.
Similar results were obtained with bone marrow cells AID Is Expressed in Sorted 493B220  or 
from / and QM mice (data not shown). Thus, we Immature B Cells
conclude that the 493 and 493 B cells from /, QM, As AID has been shown to be absolutely required for
and QM C4/ mice are immature and mature B cells, somatic hypermutation in B cells (Muramatsu et al.,
respectively, as in wild-type mice. 2000), we asked whether immature B cells express AID.
For this purpose we PCR amplified AID using the cDNA
obtained from the mRNA of the sorted populations493 Immature B Cells Express RAG Genes
Immature and pre-B cells express RAG, while mature B shown in Figure 3. As expected, AID expression was
abundant in B cells isolated from Peyer’s patches ofcells do not (Grawunder et al., 1995). Thus immature B
cells can be identified by their expression of RAG genes. the C57BL/6 mouse (Figure 3C). AID expression was
detected in the samples of 104 immature B cells fromIn order to test for RAG1 and RAG2 expression, total
RNA was extracted from sorted bone marrow B lineage the bone marrows of QM C4/ CD3/ and C57BL/6
mice (Figure 3). AID expression was also detected inpopulations and cDNA was synthesized by RT reactions
using oligo-dT primer. The cDNA was then PCR ampli- the 104 cell sample of mature B cells from the QM C4/
CD3/ mouse (Figure 3A). However, no AID expressionfied using specific primers for RAG1, RAG2, and Ig
genes. The intensity of the  bands was taken as a was found in any samples of pro-/pre-B cells from the
QM C4/ CD3/ or C57BL/6 mice (Figure 3). Thesemeasure of the number of cells sampled. RAG1 and 2
gene expression were easily detected by RT-PCR in data indicate that AID is expressed in immature phe-
notype B lymphocytes from QM C4/ CD3/ and102 pre-B cells (493) of a QM C4/ CD3/ mouse
(Figure 3A). In the immature B cells (493) RAG1 was C57BL/6 mice, as well as in mature phenotype cells
from QM C4/ CD3/ mice. We also conclude thatdetected in a 104 cell sample, while RAG2 can be de-
tected in a 103 cell sample. Cell samples from QM, QM AID expression in the bone marrow B cells is T cell
independent. Similar data regarding AID and Rag ex-C4/ mice produced similar results (data not shown).
In a C57BL/6 mouse, RAG1/2 expression in pro-/pre-B pression was obtained from a QM C4/ mouse (data
not shown).could be detected in 103 and 104 cell samples (102 was
Immunity
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Figure 3. RT-PCR Detection of RAG1, RAG2,
and AID in Sorted Bone Marrow Cells
(A–C) From (A) a QM C4/ CD3/ mouse,
(B) sorted cells of bone marrow, and (C) Pey-
er’s patches of a C57BL/6 mouse. The no
cDNA lane is a negative control, and 103/4 (an
Abelson murine leukemia virus transformed
bone marrow pre-B cell line) was used as a
positive control. RT-PCR for  was done to
confirm the presence of RNA in the samples.
(D) Summary of results of RAG and AID ex-
pression at the single-cell level. Total number
of single cells analyzed is represented by the
total number of wells positive for GAPDH. #,
single immature B cells from various QM mice
and mature B cells from C57BL/6 Peyer’s
patch. *, one cell expressed AID and Rag1
simultaneously. ‡, mutation frequency was
obtained from genomic PCR of bulk samples.
†, numbers represent number of positive cells
obtained with RT-PCR. ND, not done.
In order to determine whether the individual cells ex- 58  15%, which was significantly higher than the 20 
press both AID and RAG, single-cell RT-PCR for these 11% found in immature and mature B cell samples (p 	
genes was performed. Mature single B cells from 107, one-tailed, unequal variance t test). The frequency
C57BL/6 Peyer’s patch were used as controls, and as of mutations in  cDNA clones from pre-B samples from
expected, they express AID but no RAG (Figure 3D). We all the mice analyzed was 2.5  3.0 per 104 bp (n 

found that only a small fraction of immature B cells 233, n being the number of clones sequenced; data not
express AID (Figure 3D). In addition, AID and RAG genes shown). This represents a slight increase in the fre-
were not coexpressed in most immature B cell analyzed, quency of mutations when compared to the mutation
but we found that one of nine AID-positive immature B frequency of C regions (0.6  1.4 per 104 bp) in these
cells also expressed Rag1 (Figure 3D). These results clones (p 	 0.024, one-tailed, paired t test). However,
might indicate that AID expression is initiated at a stage when compared to the frequency of mutations in all (n

in B cell maturation at which RAG expression is ending. 1589) sequenced C regions (1.5  1.5 per 104 bp), it is
not significantly different (p	 0.065, two-tailed, unequal
variance t test). The frequency of mutations in the C isSomatic Mutation in V Genes in B Cells
quite similar to the calculated error rate of the pfu DNAfrom /, QM, and QM C4/ Mice
polymerase, which, under our experimental conditionsUsing cells isolated from the bone marrow of 11-week-
was 1.2  1.2 per 104 bp for the housekeeping gene,and 6-month-old mice, we looked for mutations in the
S14 (n 
 54) (Figure 4B and data not shown).cDNA of rearranged V genes. In the sorted 493,
In contrast to the findings in pre-B cells, mutationspre-B cells (Figure 4A), VRNA transcripts were detected
were found in the V genes of immature 493 B cells ofby RT-PCR (data not shown). This result suggests that
two of the six / and two of two QM mice. Theselight chain rearrangement had just been completed in
occurred at similar frequencies (Figure 4B) and rangessome of the sorted pre-B cells. This conclusion was
(Figure 5). The average mutation frequency was 10 supported by the finding that in the pre-B cell samples,
104 per bp, roughly ten times higher than our error rate. light chain cDNA sequence analysis showed that the
frequency of reading frame shifts at VJ junctions was The 493 mature B cells from these mice had variable
Somatic Hypermutation in Immature B Cells
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Figure 4. V Genes from the BM-Derived B
Cells Contain Mutations
(A) An example of cell sorting of three cell
subsets as shown in the boxed populations
493 pre-B cells, 493 (immature) B
cells, and 493 (mature) B cells. The BM
cells from /, QM, QM C4/, and QM C4/
CD3/ were stained with 493 and anti- an-
tibodies. The purity of the sorted cells was
routinely around 94% to 99%.
(B) Mutation frequency in the V and C re-
gions of the immature and mature B cells.
Rearranged  genes were amplified either by
RT-PCR or genomic PCR as indicated and
cloned. The average mutation frequency for
the C regions is 1.5  1.5 per 104 bp.
mutation frequencies, ranging from background to 42  mutation frequency than their immature counterparts
(p 	 0.03, two-tailed, unequal variance t test). These104 per bp (Figures 4B and 5). Although there were
similar mutation frequencies in the immature and mature mutations were associated with a higher percentage of
mutant clones and more mutations per clone (Figure 5).B cells (Figures 4B and 5), the underlying mutations
in these two groups were different. For example, they Thus, loss of C4 has little influence on somatic mutation
in 493 B cells but is associated with an increase indiffered in the frequency of mutations of G/C base pairs
(see below), implying different mutation and/or selection mutations in mature B cells. These results provide evi-
dence that the mutated 493 B cells were neither con-processes in mature and immature B cells. These data
clearly indicate that the 493 (immature) B cells had taminating mature 493 B cells nor were they likely to
be their descendants.somatic mutations. The variability in occurrence of mu-
tations in individual mice and cell populations could As a small number of contaminating plasma cells,
producing large amounts of Ig mRNA, could distort RT-be due to the degree of heavy chain diversity in these
different groups of mice or reflect the different genetic PCR results, genomic-PCR of rearranged  genes was
done. In two QM C4/ mice and two of four QM C4/backgrounds; however, the issue needs to be further in-
vestigated. mice, the mutation frequencies found in genomic DNA
samples from immature B cells (B220493) wereThe mutation frequencies and range of mutations in
493 B cells from QM C4/, QM, and / mice were comparable to those obtained with RT-PCR (Figure 4).
In addition, AID was found to be expressed in some ofsimilar (Figures 4B and 5). Mature 493 B cells of two
of the three QM C4/ mice had about a 4-fold greater these cells (Figure 3D). Taken together, the data from
Immunity
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Figure 5. Mutation in the V Clones from the 493 (Immature) and 493 (Mature) B Cells
The mouse source is shown above. Each pie chart depicts the proportion of sequences with mutations. Numbers outside of each pie are the
number of mutations. The size of each wedge coded with varying shades of gray is proportional to the percentage of clones carrying that
number of mutations. Inside each pie is the number of clones sequenced.
both cDNA and genomic-DNA clones suggest that im- region of  light chain gene of mature B cell population
from mouse two seems higher (5  104 per bp) thanmature B cells from these mutant mice have somatic
hypermutation. the average mutation frequency (1.6 104 per bp). This
result could be due to random variation or to somatic
mutation in the  constant region as previously reportedT Cell-Independent Mutation in Immature B Cells
Somatic hypermutation occurs in newly derived B cells (Motoyama et al., 1991). These data indicate that T cells
are not required for somatic mutation in the V regionin sheep ileal Peyer’s patches in a T-independent man-
ner (Reynaud et al., 1995). The observation of somatic early in B cell development.
hypermutation in murine 493 immature B cells raises
the question whether T cells are required for this pro- Mutations Were Not Detected in Bone Marrow B Cells
in Mice with an Intact Ig Repertoirecess. To determine this, we looked for mutations in QM
C4/ CD3/ mice. In order to determine whether mutations can be found
in mice with an intact V gene repertoire, we choseSomatic mutation has been associated with DNA dou-
ble-strand breaks (Bross et al., 2000; Sale and Neu- C57BL/6, C4/, and CD3/ mice for analysis (Figure
5 and data not shown). Mutations were not found in theberger, 1998), and is regulated by the cell cycle (Papa-
vasiliou and Schatz, 2000). We therefore focused our sorted pre-, immature, or mature B cells of C57BL/6
mice (250 clones in three experiments, six age-matchedanalysis on the large, dividing bone marrow 493 (data
not shown) and 493 B cells (therefore, the results from mice). In addition, no mutations were found in either an
eleven-week-old C4/ mouse (103 clones) or in twothese mice can not be directly compared with those of
other mice). We sorted the large 493 and 493 B CD3/ mice (4.5 months old, 35 clones). These results
indicate either that, when  chains are expressed, muta-cells from a QM C4/ CD3/ mouse in two separate
experiments. Mouse one was 17 weeks old; mouse two tion of  genes does not occur, or, more likely, that in
the presence of -expressing B cells -mutated cellswas 28 weeks old. In the immature B cells of both of
these mice, a significant number of mutations were are not clonally expanded to the point that allows their
detection by the methods employed.found in the V compared to the C regions in the same
clones (p 	 0.002, one-tailed, paired t test) (Figures 4B
and 5). Mutations were also found in the mature B cells Nature of the Mutations
Analysis of the pattern of nucleotide targeting showedfrom one of the two mice (mouse two) (Figures 4B and
5). The frequency of mutation (Figure 4B) in the constant that 58  4% of the mutations in immature and 54 
Somatic Hypermutation in Immature B Cells
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Table 1. Pattern and Frequency of Mutations in V Genes of Immature B Cells
A. Significant Increase of C to T Mutations in Immature B Cells Compared to Those in Mature B Cells
Original Final Nucleotide (Mutated)a
Nucleotide
Cell Type (Germline) T C G A Totalc
Immature B cells T 6b 1 3 10
C 23d 4 2 29
G 1 6 22 29
A 8 8 16 32
Mature B cells T 6 1 2 9
C 16 4 3 23
G 3 6 22 29
A 12 10 16 37
B. Lower Mutation Frequency of V Genes from Immature B Cells Compared to the Published V Mutations from Putative Memory B
Cells
Mutationse Mutations/bp in VJf
Peyer’s
Segmentg Nucleotides 493 (n 
 61) 493 (n 
 51) 493 493 Patchh QM PBi
L 57 5 4 1.4 1.4
FR1 69 21 16 5 4.5 5 24
CDR1 42 38 60 15 28 38 15
FR2 45 22 25 8 11 14 19
CDR2 21 18 32 14 30 51 60
FR3 96 25 38 4 8 14 22
CDR3 21 21 28 16 26 44
J 39 10 9 4 4.5 7
V/J 384 160 202 6.8 10 20 23
R/Sj 1.9 2.6 3 3.8
a The total number of observed mutations in V1 and 2 from /, QM, QM C4/, and QM C4/ CD/ was 155 in immature and 199 in
mature B cells. Numbers represent the percentage of nucleotide changes in V genes. Deletions were excluded. Data in this table were from
RT-PCR.
b Percentage of nucleotide change is corrected for base composition of V1 according to the method of Gojobori et al. (1982). Correction
based on V 2 gives almost identical results.
c Total by row.
d By 2 test p 	 0.015 compared to C to T mutations in mature B cells.
e Number of mutations observed within each segment is indicated. N, number of mutant clones analyzed. Data in this table were from RT-PCR.
f Mutations/bp is number of mutations/segment length/mutated clone number  1000.
g L, leader; FR, framework; CDR, complementary determining region; J, joining region.
h From B220 PNAhi Peyer’s patch B cells (Gonzalez-Fernandez et al., 1994).
i Adapted from B220, idiotype-positive B cells from peripheral blood (PB) (Cascalho et al., 1998).
j Replacement versus silent mutations.
16% in mature B cells were in G/C base pairs (Table 1A deletions included) and 55% of the mature mutations
(202 total, three deletions included) were in these hot-and Supplemental Table S1 at http://www.immunity.
com/cgi/content/full/20/2/133/DC1). 23  9% of muta- spots or their inversions (WRCY and TTA) (Figure 6).
Thirty-four of the 73 hotspot mutations from the 493tions in immature B cells were C to T transitions com-
pared to an average of 16  8% in the mature B cells B cells were in RGYW, 32 in WRCY, 2 in TTA, 1 in TAA,
2 in overlap of TAA and RGYW, and 2 in an overlap of(p 	 0.015, 2 test). The average of C to T changes in
mouse Peyer’s patches was reported to be 17  4% RGYW and WRCY. Fifty four of the 108 hotspot muta-
tions from the 493 B cells were in RGYW and TAA, 50(Bertocci et al., 2002; Betz et al., 1994; Frey et al., 1998;
Gonzalez-Fernandez et al., 1994; Gonzalez-Fernandez in WRCY and TTA, and 4 in an overlap. The mutations
we found in the immature B cells thus show featuresand Milstein, 1993; Yelamos et al., 1995) (p 	 0.022,
compared to C to T from immature B cells, 2 test). We previously described as common in somatic hypermuta-
tion of Ig genes: they occur at hotspots and in bothconclude that C to T changes occur more frequently in
immature than mature B cells. strands of DNA (Dorner et al., 1998; Milstein et al., 1998).
Several positions are favored mutation targets (OpreaMany studies have shown that the location of muta-
tions in V genes is higher in so-called hotspots with the et al., 2001; Shapiro et al., 1999, 2002). In the immature B
cells, mutations in nucleotide positions 77 (ACT, Thr27)motifs RGYW (R 
 A or G, Y 
 C or T, W 
 A or T) and
TAA (Betz et al., 1993; Rogozin and Kolchanov, 1992). (where the mutated nucleotide position is underlined
followed by the amino acid three-letter code and itsWe therefore analyzed the somatic mutations we found
in bone marrow-derived B cells to determine if they were location), 91 (ACT, Thr29), 101 (TAT, Tyr32), 170 (GCT,
Ala55), and 284 (AGC, Ser93) were the favored targetsalso localized to hotspots. We calculated the percent-
age of mutations that falls within these hotspots. In the for mutation (Figure 5). The AGC and GCT previously
described as the two most targeted triplets for mutationclones examined, 46% of immature (160 total in VJ, five
Immunity
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Figure 6. Point Mutations in the VJ Gene Segment of the BM B Cells Are Preferentially Located in the Hotspots and Their Inversions
(A–D) Hotspot TAA, its inversion TTA, hotspot RGYW, and its inversion WRCY in the VJ (Vx is not included).
(E) Distribution of point mutations in VJ in the 493 (immature) and 493 (mature) B cells. Mutant clones from /, QM, QM C4/, and
QM C4/ CD3/ made from RT-PCR are included in this analysis. The immature B cells analyzed resulted in 61 mutant/404 total clones
and the mature B cells in 51 mutant/323 total clones. The x axis indicates nucleotide position; y axis indicates number of mutations. The axis
on the right represents the percent of mutations located at a particular nucleotide position among total mutations. The dominant individual
hotspots are indicated with the position of the nucleotide.
(Oprea et al., 2001; Shapiro et al., 1999) were mutated which is lower than the reported R/S ratios of 3 and
3.8 in Peyer’s patch B cells (Gonzalez-Fernandez et al.,nine and five times, respectively. The ACT and TAT were
mutated six times each in the immature B cells. The 1994) and in circulating B lymphocytes of peripheral
blood of QM mice (Cascalho et al., 1998), respectivelyACT was mutated four times. All except the TAT are in
known hotspots. The A in the TAT (Tyr 32) is flanked by (Table 1B). Furthermore, mutations per 1000 bp in VJ
were lower in the 493 than in 493 B cells. In addition,a hotspot on each side. Mutations occurred in more
hotspots and TAT triplets in the mature B cells. The the reported frequency of mutations in the 1 genes of
putative memory B cells from Peyer’s patches in normalcombined mutations at positions 77, 101, 170, and 284
account for 16% of the total mutations in immature B mice (Gonzalez-Fernandez et al., 1994) or peripheral
blood of QM mice (Cascalho et al., 1998) (Table 1B) werecells compared to 10% of the total mutations in mature
B cells. Thus, these data suggest that the immature B much higher than we observed in the bone marrow B
cells. Thus, it is unlikely that mutations found in 493 Bcells have more focused targeting of mutations in a few
hotspots compared to the mature B cells. cells were from circulating memory type B cells found
previously in QM mice. We conclude that mutation oc-There is an association of an enhanced replacement
(R)/silent (S) mutation ratio (R/S ratio) with increased curs in B cells with immature phenotype in the bone
marrow. Unlike mutations in germinal center B cells theaffinity maturation of B cell receptors (Berek and
Milstein, 1987; Weigert et al., 1970). Our data show that, mutations in immature B cells are C biased and are more
focused to a few hotspots.in the immature B cells, the R/S in the three CDRs was
similar to that in the mature B cells: 3.3 and 2.9 for
the immature and mature B cells, respectively (data not Discussion
shown). These values are only slightly higher than the
expected ratio of 2.7, assuming unselected random mu- To date, somatic hypermutation in mice was found to be
associated with the postantigenic stages of the immunetations. The overall R/S ratios for the 493 immature
and 493 mature B cells were 1.9 and 2.6, respectively, response and limited to mature, memory, and plasma
Somatic Hypermutation in Immature B Cells
141
cells. Thus, our finding of mutations in the bone marrow- from QM C4/ CD3/ mice, providing evidence of
T-independent activation of AID in vivo. These resultsderived 493 B cells raises a question regarding the
identity of this population in the /, QM, and QM C4/ extend a previous report that T-independent activation
of a B cell line can induce AID expression in vitro (Failimouse models. We addressed this in three ways: by the
analysis of surface markers, by BrdU labeling, and by et al., 2002).
Weller et al. have proposed a hypothesis of two path-molecular analysis. The majority of 493 cells from the
bone marrow of these mice have immature surface ways of somatic hypermutation, one that is dependent
on and the other independent of CD40 signals (Wellermarkers and the rest transitional markers. Furthermore,
they are rapidly turning over (Figures 1 and 2), a feature et al., 2001). In addition, somatic hypermutation studies
of Ig genes in Msh2/ mice led to the proposal of acharacteristic of immature B cells in normal mice. The
2% renewal rate of the 493 cells is similar to rates seen two-stage model of mutations, in which hotspot-
focused, G/C-biased mutations are followed by Msh2-in several mouse strains (Allman et al., 2001; Opstelten
and Osmond, 1983). In addition, these 493 B cells ex- dependent mutations that are biased toward A/T (Rada
et al., 1998). Our data showing high C to T nucleotidepress RAG genes (Figure 3), a hallmark molecular marker
of pre-B and immature B cells (Grawunder et al., 1995; changes in immature B cells suggests the possibility
that somatic hypermutation operates in two differentMonroe et al., 1999).
Bone marrow is a rich source of memory and plasma fashions. During B cell development mutation is AID
dependent and T cell independent but in germinal cen-cells (Manz et al., 1997; Slifka et al., 1998; Smith et al.,
1997), which, by contamination, could account for the ters it is T dependent and requires AID plus Msh2 and/
or other factors.somatic mutations in sorted “493” B cells. These mem-
ory and plasma cells have several common features: The finding of AID expression in early B cell develop-
ment clearly indicates that somatic hypermutation couldtheir B cell receptors are frequently class switched and
they have a high frequency of somatic mutations in their play an important role in enlarging the Ig repertoire
and/or rescuing self-reactive B cells. In some respects,V genes (Smith et al., 1997). However, more than 98%
of the 493 were IgM (data not shown). Comparisons mutation in the immature B cells of mice is reminiscent
of mutations found in sheep (Reynaud et al., 1995). Inof mutations in V genes of immature 493 B cells with
putative memory circulating B cells of QM mice, or with sheep, somatic hypermutation occurs in newly derived
B cells without T cell help. Similarly, in the adult miceputative memory cells from Peyer’s patches (Gonzalez-
Fernandez et al., 1994) indicate that they differed signifi- with a restricted Ig repertoire that we describe, mutation
was limited to some animals, and in these, only aboutcantly in mutation frequency and in pattern of nucleotide
bias (Table 1B). Thus, contaminating memory and 20% of the immature B cells were mutated.
No mutations were found in bone marrow-derived ma-plasma cells are unlikely sources of the mutations seen
in the 493 B cell populations. That the mutations found ture or immature  light chain genes of C57BL/6, C4/,
or CD3/ mice, yet mutations were found in  lightin  light chain genes in sorted 493 B cells are not due
to contaminating mature 493 B cells is supported by chain-restricted mice: /, QM, QM C4/, and QM
C4/ CD3/. We did find, however, expression of AIDthe observation that, in the QM C4/ mice, an increase
in the frequency of mutations in the mature 493 B cells in immature B cells from wild-type mice (Figure 3B).
The extreme pressure on B cells to diversify due to theis not reflected by an increase in the mutation frequency
in the 493 cells. limited repertoire of V genes might cause an expansion
of many clones of mutated B cells in the /, QM, andC4 participates in generating B cell tolerance and en-
hances B cell signaling by antigen through linking of QM-derived mice, while in normal mice expansion might
occur only at a much lower frequency. Thus, althoughthe CD19/CD21 coreceptor with the BCR (Fearon and
Carroll, 2000). It has been proposed that C4 transports these mutations were only detected in these genetically
manipulated mice, that they occur at all indicates thatsoluble self-antigens to CD21/CD35 within the bone
marrow and secondary lymphoid tissues and thereby this type of mutation mechanism is generally available.
However, the mechanisms generating somatic hyper-plays a critical role in the induction of anergy (Prodeus
et al., 1998). Thus, one possible explanation for the in- mutation in developing B lymphocytes may not be oper-
ative in normal mice. Like the secondary rearrangementscreased frequency of mutation in mature B cells of QM
C4/ mice is that self-reactive B cells are chronically of VH and VL genes found in cells expressing self-reactive
Ig transgenes (Gay et al., 1993; Pelanda et al., 1997;activated by self-antigens, leading to an accumulation
of mutations. Alternatively, as previously suggested Tiegs et al., 1993), or in self-reactive B cells of autoim-
mune mice (Klonowski et al., 1999), somatic mutation(Chen et al., 2000), because C4 complexed with antigen
crosslinks the BCR with the CD21/CD19 coreceptor, at the immature B cell stage might also occur in re-
sponse to self-antigen binding. As with secondary re-an absence of C4 may lead to the selection of B cells
producing higher-affinity antibodies. This would allow arrangements, this would be a mechanism that would
serve to alter the specificity of otherwise self-reactivemaintenance of a full number of B cells despite a reduc-
tion in signaling via the coreceptor CD21/CD19 due to cells. Such a mechanism would provide an explanation
for results obtained when the anti-ssDNA Ig 3H9/V8C4 deficiency.
Another important element for the process of somatic transgenes were bred onto the autoimmune MRL/lpr
background (Brard et al., 1999). In this case, the targetedhypermutation is AID. AID expression has been detected
in Peyer’s patch, splenic, and bone marrow cells by RT- V8 light chain gene had G/C-biased mutations, one of
which rendered the gene nonfunctional, allowing subse-PCR (Muramatsu et al., 1999). We extend these findings
by showing AID expression in the bone marrow imma- quent rearrangement of endogenous V23 light chain
genes. The targeted 3H9 VH gene also had G/C-biasedture and mature B cells of wild-type and mutant mice
(Figure 3). In addition, we find expression of AID in cells mutations. Some of these mutations could have taken
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0.5 U Platinum Taq DNA polymerase) (Invitrogen). Oligonucleotideplace during B cell development without the need to
primers used for RT-PCR amplification are described in the Supple-invoke reactivation of RAG genes at the mature B cell
mental Data.stage. It will be very important to investigate whether
the higher rate of somatic mutations found in systemic Genomic PCR of  Genes
lupus erythematosus patients (Dorner et al., 2001) is in PCR using purified genomic DNA and pfu DNA polymerase (Stra-
tagene) was done at 95C, 1 min 45 s; 35 cycles at 95C, 20 s; 60C,part due to an increased rate of somatic mutation in
30 s; and 72C, 40 s, followed by a 30 min final extension at 72Cdeveloping B cells.
with primers 0.2 M UVLN, 0.1 M JL1R, and 0.1 M JL23R.
Experimental Procedures
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